Partner Content Partner Content Focus day announced for SMi’s 11th annual RNA Therapeutics c... SMi Reports: RNA Therapeutics conference and focus day to return on February 2020, in London
Events Partner Content 2nd RNA Targeted Drug Discovery Summit At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the
News BMS looks to RNA splicing to boost immunotherapies Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and its US-based precision medicine subsidiary H3 Biomedicine to
News Dicerna agrees another gene-silencing deal, this time with L... Eli Lilly has agreed a broad collaboration with Dicerna, sealing the deal with a $100 million equity stake in the RNA interference specialist.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
